RCM
TMDX icon

RB Capital Management’s Transmedics TMDX Stock Holding History

RB Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$337K Hold
5,081
– – 0.07% 151
2026
Q1 		$505K Hold
5,081
– – 0.11% 125
2025
Q4 		$618K Hold
5,081
– – 0.12% 118
2025
Q3 		$570K Buy
5,081
+2,093
+70% +$245K 0.12% 123
2025
Q2 		$400K Hold
2,988
– – 0.09% 131
2025
Q1 		$201K Buy
+2,988
New +$206K 0.05% 173
2024
Q4 		– Sell
-1,371
Closed -$215K – 193
2024
Q3 		$215K Hold
1,371
– – 0.05% 175
2024
Q2 		$207K Buy
+1,371
New +$164K 0.05% 171

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

RB Capital Management's TMDX Position: Q2 2026 in Review

RB Capital Management held its Transmedics (TMDX) position steady in Q2 2026 at 5,081 shares worth $337K. The position accounts for 0.07% of the portfolio, ranked #151.

RB Capital Management first reported a position in TMDX in Q2 2024 and has held it in 8 quarters since. The position peaked at $618K in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • RB Capital Management held 5,081 shares of Transmedics worth $337K as of Q2 2026.
  • RB Capital Management left its Transmedics share count unchanged in Q2 2026.
  • Transmedics made up 0.07% of RB Capital Management's portfolio in Q2 2026, its #151 holding.
  • RB Capital Management first reported a position in Transmedics in Q2 2024 and has held it in 8 quarters since.
  • RB Capital Management's Transmedics position peaked at $618K in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on RB Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.